Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs
Opdam, M. A. A., Broeder, N.den, van den Bemt, B. J. F., Mulder, K., van de Wiel, K. M., van Ballegooijen, H., van Crevel, R., den Broeder, A. A.
Published in Clinical rheumatology (01.06.2024)
Published in Clinical rheumatology (01.06.2024)
Get full text
Journal Article
POS1070 SLIGHTLY INCREASED INFECTION RISK FOR JAK INHIBITORS TOFACITINIB AND BARICITINIB COMPARED TO BDMARDS: A REAL-WORLD EVIDENCE STUDY
Opdam, M, Den Broeder, N, Van den Bemt, B, Mulder, K, K M Van de Wiel, H Van Ballegooijen, R Van Crevel, Den Broeder, A
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
CL4 Concerns, Quality of Life, Access to Care and Productivity of the General Population during the First 8 WEEKS of the Coronavirus Lockdown in Belgium and the Netherlands
Michels, R., Goossens, L.M.A., Bruin, R., van Ballegooijen, H., Krol, M.
Published in Value in health (01.12.2020)
Published in Value in health (01.12.2020)
Get full text
Journal Article
OC 74.4 Prevalence and Predictors of Non-Adherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation, a Historical Cohort Study
van der Horst, S., de Vries, T., Chu, G., Bavalia, R., Xiong, H., van de Wiel, K., Mulder, K., van Ballegooijen, H., de Groot, J., Middeldorp, S., Klok, E., Hemels, M., Huisman, M.
Published in Research and practice in thrombosis and haemostasis (01.10.2023)
Published in Research and practice in thrombosis and haemostasis (01.10.2023)
Get full text
Journal Article